Clinical Trial Update: Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin [Phase 1]

View source ↗

Summary

Phase 1 study evaluated the effect of a high-fat meal on the bioavailability and pharmacokinetics of a single dose of moxidectin; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease

Drugs mentioned

• Moxidectin (moxidectin)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Infection | Phase 1 | Status: COMPLETED